Lorenzo's Oil ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 20 | 副腎白質ジストロフィー | 3 |
20. 副腎白質ジストロフィー
臨床試験数 : 53 / 薬物数 : 88 - (DrugBank : 31) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 123
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02233257 (ClinicalTrials.gov) | August 2011 | 5/5/2014 | Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy | Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy | X-linked Adrenoleukodystrophy | Drug: Lorenzo's Oil | University of Minnesota | NULL | No longer available | 18 Months | 18 Years | Male | United States | ||
| 2 | NCT00545597 (ClinicalTrials.gov) | March 2005 | 16/10/2007 | A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy | A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy | Adrenomyeloneuropathy;Adrenoleukodystrophy | Drug: Lorenzo's oil | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Food and Drug Administration (FDA) | Terminated | 18 Years | N/A | Both | 240 | Phase 3 | United States |
| 3 | NCT00004418 (ClinicalTrials.gov) | April 1998 | 18/10/1999 | Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy | Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy | Adrenoleukodystrophy | Drug: glyceryl trierucate/glyceryl trioleate | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | NULL | Terminated | 18 Months | 8 Years | Male | 126 | Phase 2 | United States |